Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional verapamil + triamcinolone versus intralesional triamcinolone for treatment of keloid
TCTR20251117012Phase 4Recruiting
- Sponsor
- Muhammad Tayyab Iqbal
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of verapamil, triamcinolone in keloid, sponsored by Muhammad Tayyab Iqbal. Started Nov 2025; status: recruiting.
02
Drugs
verapamiltriamcinolone
03
Conditions
keloid
Beyond the preview
Go deeper on TCTR20251117012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251117012.